NGS and emerging molecular scenarios in chronic myeloproliferative neoplasms: a case of double mutated polycythemia vera. [PDF]
Cerchiara E +9 more
europepmc +1 more source
Calreticulin Type 26 Mutation in Myelofibrosis: A Rare Variant With Diagnostic Challenges. [PDF]
Maltese T +6 more
europepmc +1 more source
Precision medicine in myelofibrosis: from molecular profiling to personalized therapy. [PDF]
Al-Shibly R +3 more
europepmc +1 more source
CDK6 inactivation counteracts CALR-mutant-induced MPN evolution and sensitizes MPN stem cells to interferon-α treatment. [PDF]
Ringhofer B +18 more
europepmc +1 more source
MPL mutations are over-represented in patients with dual driver-mutated myeloproliferative neoplasms: an Irish cohort study. [PDF]
Kearney L +14 more
europepmc +1 more source
HSP90AA1 Knockdown Enhances Doxorubicin Sensitivity by Promoting Immunogenic Cell Death-Related Signaling and Immune-Related Tumor Microenvironment Remodeling in Breast Cancer. [PDF]
Chen R +6 more
europepmc +1 more source
Integrating Next Generation sequencing into the risk assessment of primary myelofibrosis. [PDF]
Reis-Vieira R +10 more
europepmc +1 more source
Megakaryocytes in myelofibrosis: mechanisms of fibrotic niche remodeling and therapeutic implications. [PDF]
Huang J +9 more
europepmc +1 more source

